NicOx: Clinical Trials

6 trials sponsored by NicOx, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

6 completed. 6 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	6	Completed 6

Follow NicOx: new trials by email

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male naproxcinod 750 bid, naproxcinod 3000 mg od, naproxen 500 mg bid - Pharmacokinetics	Phase 1	Completed	NicOx	24	2010-01-01	2011-08-11
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide naproxcinod, Naproxen, placebo - Renal Hemodynamics	Phase 1	Completed	NicOx	31	2009-01-01	2011-06-17
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function naproxcinod - Renal Failure	Phase 1	Completed	NicOx	32	2008-05-01	2009-01-28
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure naproxcinod 375 mg -750 mg -1125 mg bid, naproxen 250 mg - 500mg -750 mg bid - Osteoarthritis, Hypertension	Phase 1	Completed	NicOx	120	2008-03-01	2011-06-17
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension naproxcinod 375 mg bid, naproxcinod 750 mg bid, naproxen 250 mg bid - Osteoarthritis, Hypertension	Phase 1	Completed	NicOx	300	2008-03-01	2011-06-17
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects naproxcinod - Liver Disease	Phase 1	Completed	NicOx	24	2008-01-01	2011-06-17

Conditions studied

Interventions

Countries

Top investigators